Antoine Hollebecque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antoine hollebecque. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antoine Hollebecque Today - Breaking & Trending Today

RLY-4008 Shows Initial Activity With a Manageable Safety Profile in Cholangiocarcinoma

Mitesh J. Borad, MD, highlights key additional findings from ReFocus and how RLY-4008 differs from currently available FGFR2 inhibitors. ....

United States , Mayo Clinic Comprehensive Cancer Center , Treatment Options For The Management Of Patients With Cholangiocarcinoma , Rly 4008 , Refocus Trial , Miteshj Borad , Mayo Clinic , Topaz 1 Trial , Antoine Hollebecque , Gustave Roussy Cancer Center ,

Ongoing Investigation of RLY-4008 Highlights Evolving Treatment Options for FGFR2+ Cholangiocarcinoma

R. Kate Kelley, MD, details the ongoing investigation of RLY-4008 for patients with advanced cholangiocarcinoma harboring FGFR2 fusions or rearrangements, other ongoing investigations in cholangiocarcinoma, and the importance of molecular testing to drive treatment decisions in this population. ....

United States , San Francisco , Antoine Hollebecque , Lipika Goyal , R Kate Katie Kelley , Department Of Medicine Hematology Oncology , Virtual International Conference On Molecular , Cancer Immunotherapy Program , University Of California , International Conference , Molecular Targets , Cancer Therapeutics ,

Merus N.V.: Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

Merus N.V.: Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Ezraew Cohen , Rajan Khanna , Ernesto Wasserman , Alexandre Deshiere , Kees Bol , Igor Odintsov , Jeroen Lammerts Van Bueren , Shumei Kato , Lara Iglesias , Jan Gerlach , Patricia Martin Romano , Rocio Garcia Carbonero , Antoine Hollebecque , Viktoriya Stalbovskaya , Mohamed Bekkrada , Romel Somwar , Andrew Joe , Irene Brana , Cecile Geuijen , Marc Ladanyi , Mateo Bover , Josep Tabernero , Ron Schackmann , Exchange Commission , Virtual International Conference On Molecular ,

Investegate |Merus N.V. Announcements | Merus N.V.: Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium

Merus N.V.
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics
® and Triclonics™), today announced that clinical data from its Phase 1 dose escalation study of MCLA-158 will be presented in a poster session at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium (ASCO GI) annual meeting being held virtually from January 15-17, 2021. ....

United States , United Kingdom , Mohamed Bekradda , Ernesto Wasserman , Kees Bol , Johannac Bendell , Antoine Hollebecque , Rocio Garcia Carbonero , Viktoriya Stalbovskaya , Andrew Joe , Christiane Jungels , Arjen Brinkman , Jeroen Lammerts Van Bueren , Szabolcs Fatrai , Josep Tabernero , Exchange Commission , American Society Of Clinical Oncology , Meeting Library , Merus Announces Presentation , American Society , Clinical Oncology , Cancers Symposium , Chief Medical Officer , Poster Presentation , Guillem Argil , Jeroen Lammerts ,

Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , United Kingdom , Mohamed Bekradda , Ernesto Wasserman , Kees Bol , Johannac Bendell , Antoine Hollebecque , Rocio Garcia Carbonero , Viktoriya Stalbovskaya , Andrew Joe , Christiane Jungels , Arjen Brinkman , Jeroen Lammerts Van Bueren , Szabolcs Fatrai , Josep Tabernero , Exchange Commission , American Society Of Clinical Oncology , Corporate Communications , Meeting Library , American Society , Clinical Oncology , Cancers Symposium , Chief Medical Officer , Poster Presentation , Guillem Argil , Jeroen Lammerts ,